2020-05-07 DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING

Executive Summary: NM cases. Gallup shutdown extended. Gallup hospital crisis. NM assisted living testing. University student financial relief. FDA fraudulent products. Trump/Pence test negative. India displaced repatriated. Use facemasks. Facemasks cause skin damage. PPE protocol. Michigan reopens. Illegal drug prices up. Failing masks from China. Distribution of remdesivir. CDC PPE video. Low German R0. Stay-at-home lowers Rt. Detention facility epidemiology. Saliva transmission. Healthcare informatics shortcomings. Resource allocation ethics. Uninsured drug discounts. Safer food delivery. Bat coronavirus grant axed. Dispelling common misinformation. Recommendations on managing cardiac arrest, cardiac electrotherapy and electrophysiology, hematologic malignancy, ophthalmologic screening and procedures, the use of ACEIs and ARBs. Post-COVID-19 rehabilitation. Hearing problems in children. Resuming orthopedic surgeries. NM prison testing. Qatar 0.07% mortality. Testing manufacturer nontransparency. Understanding RT-PCR vs. ELISA. Influenza infection control surrogate. 24 FDA drugs in vitro activity. NEJM hydroxychloroquine observational study. Monoclonal antibody in vitro. Lysosomal SARS-CoV-2 insights. Chloropromazine inhibits replication. Avoid HCQ in schizophrenia. Alkaloid/terpenoid protease inhibitors. Virus vaccine engineering. GSK otilimab trial. 38 new clinical trials. Virus persistence times. Outcomes for sickle cell and cancer patients. High risk thrombosis. Olfactory dysfunction. Pneumonia vs ARDS. Adapting sacubitril/valsartan. Blood thinners. Mouse study sheds light